Prostate-specific membrane antigen antibody drug conjugate (PSMA ADC): A phase I trial in metastatic castration-resistant prostate cancer (mCRPC) previously treated with a taxane.
Daniel Peter Petrylak
Research Funding - Progenics
Philip W. Kantoff
Research Funding - Progenics
Anthony E. Mega
Research Funding - Progenics
Nicholas J. Vogelzang
Research Funding - Progenics
Joe Stephenson
Research Funding - Progenics
Mark T. Fleming
Research Funding - Progenics
Nancy Stambler
Employment or Leadership Position - Progenics
Stock Ownership - Progenics
Michaela Petrini
Employment or Leadership Position - Progenics
Stock Ownership - Progenics
Kathleen Huang
Employment or Leadership Position - Progenics
Robert Joseph Israel
Employment or Leadership Position - Progenics
Stock Ownership - Progenics